ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1370	National Cancer Institute	Html	en	Colorectal Cancer Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for colorectal cancer.	adenomas 0.617512 advanced proximal neoplasia 0.563212 study 0.677803 mortality reduction 0.57851 advanced neoplasia 0.56302 CRC mortality reduction 0.544829 colonoscopy screening 0.603021 lesions 0.531993 occult blood screening 0.64042 CRC mortality difference 0.548807 CRC incidence rates 0.553335 Engl J Med 0.6404 CRC mortality 0.70138 CRC cases 0.529979 annual FOBT screening 0.529584 faecal occult blood 0.779217 Ann Intern Med 0.763728 complete colonoscopy 0.535099 colorectal cancer screening 0.676312 colonoscopy 0.785471 positive test 0.545148 colorectal neoplasia 0.540206 colorectal cancer incidence 0.537416 detection 0.55517	colorectal cancer 0.99103 CRC screening 0.62285 Abstract 0.639242 Screening Colonoscopy Program 0.575204 patients 0.584805 occult blood testing 0.542273 colonoscopy study 0.538236 CRC incidence 0.62219 systematic review 0.578714 lower CRC mortality 0.560554 virtual colonoscopy 0.591165 CRC screening program 0.568518 FIT 0.57064 Colorectal cancer mortality 0.560865 negative colonoscopy results 0.549077 concurrently performed colonoscopy 0.531966 fecal occult blood 0.884171 CRC 0.781593 sigmoidoscopy versus colonoscopy 0.551587 colorectal cancer diagnosis 0.530522 distal colon 0.542283 occult blood test 0.71312 sensitivity 0.537205	CLICK HERE
1406	National Cancer Institute	Html	en	Endometrial Cancer Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for endometrial cancer.	underwent endometrial biopsy 0.596006 exhibit similar risk 0.466243 endometrial thickness cutoff 0.594653 endometrial carcinoma 0.559295 asymptomatic women 0.56298 markedly increased risk 0.46896 endometrial biopsy 0.602665 TVU 0.506165 threshold value 0.468657 postmenopausal uterine bleeding 0.47677 hormone therapy study 0.462599 postmenopausal hormone therapy. 0.491288 additional risk factors 0.461801 endometrial cavity access. 0.584206 high survival rates 0.463126 lower survival rates 0.458386 endometrial thickness 0.608159 endometrial hyperplasia 0.560125 white women 0.528892 combination estrogen-progesterone therapy 0.467831 endometrial cancer 0.93723 U.S. women 0.465931 abnormal pathologic biopsy 0.461543 black women 0.483703 women 0.713028	unopposed estrogen therapy 0.4738 endometrial cancer. 0.591335 nonpolyposis colorectal cancer 0.479683 endometrial polyps 0.561278 endometrial aspiration 0.621101 Measuring endometrial thickness 0.597601 estrogen therapy 0.49246 Cancer Survival Study 0.480563 tamoxifen increase patients 0.459307 National Cancer Institute 0.477348 hormone therapy 0.561237 endometrial biopsy specimens 0.590423 endometrial cancer incidence 0.661899 African American women 0.535123 invasive gynecologic cancer 0.486102 advanced-stage disease 0.478186 breast cancer 0.469124 asymptomatic postmenopausal women 0.5655 primary endometrial cancer 0.608017 Project P-1 trial 0.458556 endometrial abnormalities 0.576298 National Surgical Adjuvant 0.459038 African American women. 0.461116 mean age 0.461702	CLICK HERE
1450	National Cancer Institute	Html	en	Esophageal Cancer Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for esophageal cancer.	population-based case-controlled study 0.533968 symptomatic gastroesophageal reflux 0.581421 columnar-lined esophagus 0.552922 curable neoplasms 0.466702 Barrett esophagus 0.931446 Gastric cardia adenocarcinoma 0.596066 lower esophageal sphincter 0.581561 standard histological evaluation 0.515998 gastroesophageal reflux 0.731721 squamous cell cancer 0.550703 surveillance method 0.472755 risk factors 0.526039 annual endoscopy 0.479023 esophageal squamous cell 0.594095 gastric acid production 0.530474 -relaxing drugs 0.467279 patients 0.488679 Barrett esophagus. 0.572924 GERD 0.55771 esophageal cancer incidence 0.58939 esophageal adenocarcinoma 0.818574 esophageal adenocarcinoma. 0.53156 human papillomavirus 0.478898 new cases 0.479464	gastroesophageal reflux disease 0.686421 low risk 0.472905 esophageal cancer 0.594243 H. pylori infections 0.535834 infection persisted. 0.473995 incidence rate ratio 0.524115 reflux esophagitis 0.501118 surgical resection 0.524265 low-grade dysplasia 0.493637 effective surveillance protocol 0.524901 surveillance endoscopy 0.490968 reflux symptoms 0.502651 high-grade dysplasia 0.535845 important epidemiological difference 0.530091 strong association 0.468389 expert gastrointestinal endoscopists 0.517855 duodenal ulcers 0.473231 risk factor 0.481047 Western countries 0.470134 successful resection 0.474238 cancer mortality. 0.469146 gastric infection 0.4806 risk 0.536679 intramucosal carcinoma 0.47033	CLICK HERE
1456	National Cancer Institute	Html	en	Vulvar Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of vulvar cancer.	lesion-type VIN grade 0.488217 radiation therapy arm 0.777718 vulvar surgical procedures 0.466679 sentinel node dissection 0.727156 Radiation Therapy section 0.586061 case series 0.468674 groin dissection study 0.616489 vulvar cancer 0.538035 positive sentinel nodes 0.479331 lymph node dissection 0.680638 sentinel node identification. 0.538816 invasive vulvar cancer 0.471336 vulvar cancer-related deaths 0.462293 radiation therapy issue 0.483522 clinically localized vulvar 0.482117 node dissection 0.932807 bloc inguinal node 0.506403 sentinel node dissections 0.642236 bilateral groin node 0.587002 Actuarial groin recurrence 0.544605 groin lymph 0.484094 pelvic node resection 0.498834 radical vulvectomy 0.489162 sentinel node 0.79935	high-grade vin 0.507503 bilateral dissection 0.465866 groin dissection arm 0.620835 invasive locoregional vulvar 0.48636 sentinel node procedures 0.539343 groin recurrence 0.545931 groin dissection 0.6467 femoral lymph node 0.521493 negative sentinel node 0.528158 negative sentinel nodes 0.475577 patients 0.605395 groin-node dissection 0.464 inguinal node dissection 0.663124 groin node dissection 0.784008 ipsilateral inguinal node 0.504912 pelvic radiation 0.458909 Node metastases 0.461128 groin node-positive disease 0.523738 groin radiation 0.532254 regional lymph nodes 0.463891 HPV 6/11-associated vulvar 0.461386 negative groin nodes 0.546977 systematic literature review 0.508112	CLICK HERE
1529	National Cancer Institute	Html	en	Male Breast Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of male breast cancer.	Clinical breast exam 0.284327 Breast Cancer Screening 0.314882 breast duct 0.265624 cancer spreads 0.259464 diagnose breast cancer 0.343362 malignant tumor cells 0.26356 body 0.314871 PDQ cancer information 0.299069 Inflammatory Male Breast 0.288019 clinical trials 0.336788 breast cancer stage 0.313107 cancer information summary 0.28338 clinical trial 0.259026 breast cancer prevention 0.329746 breast cancer patients 0.302243 lymph node biopsy 0.306018 sentinel lymph node 0.33726 Inflammatory breast cancer 0.359802 NCI PDQ cancer 0.260729 early localized breast 0.2726 lymph nodes 0.375271 breast carcinoma 0.267321 metastatic breast cancer 0.413709 radiation therapy 0.324944 treatment 0.354882	abnormal cells 0.280815 male breast cancer 0.548303 cancer cells 0.507692 Cancer Information Service 0.257721 specific cancer cells 0.266994 breast cancers 0.260852 National Cancer Institute 0.306996 Breast Cancer Treatment 0.32856 hormone therapy 0.286562 painful breast lesions 0.269444 lymph vessels 0.259581 new treatment 0.256083 breast cancer cells 0.328644 breast cancer 0.95341 Hereditary breast cancer 0.321208 chest wall 0.263619 Recurrent breast cancer 0.304665 IIIC breast cancer 0.305672 tumor 0.317659 treatment options 0.26574 cancer information summaries 0.256227 comprehensive cancer information 0.256173 information 0.313083 appropriate cancer treatment 0.261896	CLICK HERE
1553	National Cancer Institute	Html	en	Childhood Non-Hodgkin Lymphoma Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of childhood non-Hodgkin lymphoma.	cancer treatment 0.41722 Burkitt-like non-Hodgkin lymphoma 0.414505 panniculitis-like T-cell lymphoma 0.407586 mediastinal B-cell lymphoma 0.477834 type 0.421123 body 0.397298 childhood non-hodgkin lymphoma 0.888605 PDQ cancer information 0.389516 Non-Hodgkin Lymphoma Treatment 0.431482 clinical trial search 0.395907 B-cell non-Hodgkin lymphoma 0.444319 gamma-delta T-cell lymphoma 0.40789 clinical trials 0.596027 large cell lymphoma 0.576342 peripheral t-cell lymphoma 0.4403 clinical trial 0.545942 stem cell transplant 0.416614 Burkitt lymphoma 0.412037 anaplastic lymphoma kinase 0.405034 primary mediastinal b-cell 0.402494 diffuse large b-cell 0.419339 lymph nodes 0.504405 Pediatric-type follicular lymphoma 0.401311 large B-cell lymphoma 0.505692	radiation therapy 0.400696 childhood hodgkin lymphoma 0.422956 treatment 0.602592 Hodgkin Lymphoma Treatment 0.428936 cutaneous t-cell lymphoma 0.531706 cancer cells 0.482982 Burkitt-like lymphoma /leukemia 0.41493 HIV-related non-Hodgkin lymphoma 0.410943 certain gene changes 0.416336 Adult Non-Hodgkin Lymphoma 0.452762 recurrent lymphoblastic lymphoma 0.388804 lymphoblastic lymphoma 0.418163 follicular lymphoma 0.416701 combination chemotherapy 0.479578 non-hodgkin lymphoma 0.995932 bone marrow 0.469909 marginal zone lymphoma 0.455485 cells 0.53075 cancer clinical trials 0.407298 lymph node 0.390457 treatment options 0.51667 anaplastic large cell 0.523091 HIV-associated non-Hodgkin lymphoma 0.431952 cancer 0.673011	CLICK HERE
1559	National Cancer Institute	Html	en	Endometrial Cancer Screening (PDQ®)–Patient Version	Expert-reviewed information summary about tests used to detect or screen for endometrial cancer.	cancer treatment 0.561966 Pap test results 0.564545 ongoing clinical trials 0.564273 following PDQ summaries 0.605267 PDQ cancer information 0.713937 false-negative test result 0.559289 Uterine Sarcoma Treatment 0.562863 uterus 0.565825 Endometrial sampling 0.614718 clinical trials 0.686375 test result 0.59341 transvaginal ultrasound 0.592257 cancer information summary 0.653614 clinical trial 0.570758 test results 0.593938 breast cancer prevention 0.577475 false-positive test result 0.559048 latest published information 0.566054 PDQ® Screening 0.557798 NCI’s PDQ 0.572282 cancer symptoms 0.57367 NCI PDQ cancer 0.624163 tests 0.615659 black women 0.581998	PDQ Screening 0.598441 treatment 0.572654 cancer prevention 0.577647 screening tests 0.574176 cancer cells 0.559463 endometrial cancer screening 0.701539 Cancer Information Service 0.589993 Prevention Editorial Board 0.603972 treatment clinical trials 0.562297 National Cancer Institute 0.661886 endometrial cancer 0.979643 PDQ documents 0.56725 new treatment 0.567011 Cancer screening trials 0.628138 Cancer Care page 0.581539 PDQ database 0.570002 breast cancer 0.579583 abnormal vaginal bleeding 0.663193 non-polyposis colon cancer 0.588586 risk factor 0.558033 PDQ summary 0.615448 yearly screening 0.56313 cancer information summaries 0.594869 comprehensive cancer information 0.595413	CLICK HERE
1572	National Cancer Institute	Html	en	Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Screening (PDQ®)–Patient Version	Expert-reviewed information summary about tests used to detect or screen for ovarian, fallopian tube, and primary peritoneal cancers.	cancer treatment 0.488772 primary peritoneal cancers 0.500293 ongoing clinical trials 0.488493 following PDQ summaries 0.549415 PDQ cancer information 0.706697 false-negative test result 0.485124 fallopian tube cancer 0.565282 primary peritoneal cancer 0.815712 clinical trials 0.639646 test result 0.547906 Peritoneal Cancer Prevention 0.54551 cancer information summary 0.620799 PDQ Ovarian 0.537752 clinical trial 0.497999 breast cancer prevention 0.513915 ovarian cancer 0.852752 false-positive test result 0.536437 cancer patients 0.484043 latest published information 0.494395 peritoneal cancer form 0.545913 NCI’s PDQ 0.505993 cancer symptoms 0.504824 NCI PDQ cancer 0.581936 tests 0.532273	certain types 0.48682 black women 0.481021 PDQ Screening 0.526415 peritoneal cancer screening 0.608486 cancer prevention 0.549601 screening tests 0.485985 Cancer Information Service 0.531657 fallopian tube 0.68704 Prevention Editorial Board 0.543082 treatment clinical trials 0.485965 National Cancer Institute 0.650104 PDQ documents 0.496817 cancer doctors 0.479641 new treatment 0.493333 Cancer screening trials 0.564141 Ovarian epithelial cancer 0.582644 Cancer Care page 0.517342 PDQ database 0.501449 PDQ summary 0.536253 fallopian tubes 0.578652 cancer information summaries 0.539976 health professional versions 0.477788 comprehensive cancer information 0.539707 cancer 0.983489	CLICK HERE
1836	National Cancer Institute	Html	es	Tratamiento de la leucemia mieloide aguda y otras neoplasias mieloides malignas infantiles (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de la leucemia mieloide aguda infantil, síndromes mielodisplásicos y otras neoplasias mieloproliferativas.	frecuencia mutaciones 0.438095 LMA familiares 0.551304 leucemia eritroidea aguda 0.449843 American Academy 0.418016 Leucemia aguda eritroidea 0.453243 gen runx1t1 0.417024 neoplasias mieloides 0.421266 transient leukemia 0.421355 Sin embargo 0.442991 gen crebbp 0.417273 LMA ayuda 0.492779 necesarias mutaciones 0.436351 leucemia mielomonocítica aguda 0.45265 Panmielosis aguda 0.424398 subtipo fab 0.419671 leucemias mieloides 0.437133 Leucemia basofílica aguda 0.453074 leucemia mielógena 0.434701 Children's Oncology Group 0.430324 gen etv6 0.41685 leucemia transitoria 0.433759 reordenamiento leucemia aguda 0.452795 Leucemia megacarioblástica aguda 0.453115 Smith MA 0.431884 Leucemia aguda mielomonocítica 0.453529	gen evi1 0.417889 leucemia promielocítica aguda 0.56535 Organización Mundial 0.42957 gen mll 0.697325 células madre 0.41719 leucemia aguda 0.953312 LMA M0 0.546818 leucemia linfoblástica aguda 0.491741 SAI Leucemia 0.451225 tipo ii 0.459931 gen runx1 0.418208 Pediatr Blood Cancer 0.433879 gen cbf-beta 0.418127 M0 LMA 0.495335 leucemia monocítica aguda 0.501087 fraterno presente leucemia 0.436812 linaje mieloide 0.448127 leucemias bifenotípicas mieloides 0.422616 leucemia megacariocítica aguda 0.525006 leucemia mieloblástica aguda 0.537614 BCR-ABL1 Leucemia aguda 0.451622 leucemia mieloide aguda 0.756372 linaje linfoide 0.423692 La traslocación 0.522981	CLICK HERE
2053	National Cancer Institute	Html	es	Vacunas contra los virus del papiloma humano	Una hoja informativa acerca de las vacunas contra los virus del papiloma humano (VPH) para prevenir infecciones con ciertos tipos de VPH, los cuales son la causa principal del cáncer de cuello del útero o cérvix.	HPV prophylactic vaccines 0.314226 hpv vaccine 0.332876 Lancet Oncology 0.308843 with preexisting infection 0.306342 Mortality Weekly Report 0.31501 bivalent hpv vaccination 0.314902 largo plazo 0.306588 Disease Control 0.307862 genital warts among 0.306064 clinical trial 0.315859 anal hpv 0.312394 Estados Unidos 0.376477 hpv vaccination 0.357231 Hariri S 0.317621 Rica Vaccine Trial 0.314539 PubMed Abstract 0.885463 human papillomavirus 0.614779 vacunas gardasil® 0.319024 Infectious Diseases 0.318629 quadrivalent hpv 0.312783 Chaturvedi AK 0.307922 BMC Infectious Diseases 0.305886 hpv infection 0.324228 Hildesheim A 0.314688 Feng Q 0.308321	among young 0.314298 papillomavirus acquisition 0.305662 United States 0.307989 alto riesgo 0.531462 Updated HPV Vaccination 0.328083 British Medical Journal 0.305646 HPV Vaccination Recommendations 0.328083 Costa Rica 0.313988 Immunization Practices 0.308391 Advisory Committee 0.307786 papillomavirus among 0.306019 infecciones persistentes.  gardasil 0.336098 9-valent human papillomavirus 0.32439 papillomavirus prophylactic vaccines 0.30978 Bocchini JA 0.307795 ¿Cuáles cánceres 0.312957 Hughes JP 0.308264 bivalent hpv 0.331056 cuello uterino 0.992097 Vaccine Safety Datalink 0.314052 genital hpv infection 0.315334 Cancer Institute 0.307587 New England Journal 0.348895 Petrosky E 0.307326	CLICK HERE